Eagle Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $48.7M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $93.4M | Sell |
|
|||||
|
2022
Q3 | $57.1M | Sell |
|
|||||
|
2022
Q2 | $106M | Buy |
|
|||||
|
2022
Q1 | $138M | Sell |
|
|||||
|
2021
Q4 | $154M | Sell |
|
|||||
|
2021
Q3 | $166M | Sell |
|
|||||
|
2021
Q2 | $173M | Sell |
|
|||||
|
2021
Q1 | $220M | Buy |
|
|||||
|
2020
Q4 | $169M | Sell |
|
|||||
|
2020
Q3 | $229M | Buy |
|
|||||
|
2020
Q2 | $120M | Buy |
|
|||||
|
2020
Q1 | $55.4M | Sell |
|
|||||
|
2019
Q4 | $68.3M | Sell |
|
|||||
|
2019
Q3 | $68.2M | Sell |
|
|||||
|
2019
Q2 | $64.8M | Sell |
|
|||||
|
2019
Q1 | $71.3M | Sell |
|
|||||
|
2018
Q4 | $52.9M | Sell |
|
|||||
|
2018
Q3 | $54.2M | Buy |
|
|||||
|
2018
Q2 | $39.8M | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $26.5M | Buy |
|